CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth.
about
CXCL14 as an emerging immune and inflammatory modulatorThe integrative roles of chemokines at the maternal-fetal interface in early pregnancyTumor stroma as targets for cancer therapyInhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent.Differences in the nemosis response of normal and cancer-associated fibroblasts from patients with oral squamous cell carcinomaIL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathwayIonizing radiation abrogates the pro-tumorigenic capacity of cancer-associated fibroblasts co-implanted in xenografts.Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.Distinctive responsiveness to stromal signaling accompanies histologic grade programming of cancer cellsFibroblast heterogeneity in the cancer wound.Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cellsMacrophage Infiltration in Tumor Stroma is Related to Tumor Cell Expression of CD163 in Colorectal Cancer.p53 status in stromal fibroblasts modulates tumor growth in an SDF1-dependent manner.A systems genetics approach identifies CXCL14, ITGAX, and LPCAT2 as novel aggressive prostate cancer susceptibility genes.Biological characteristics and genetic heterogeneity between carcinoma-associated fibroblasts and their paired normal fibroblasts in human breast cancerEffect of chronic restraint stress on human colorectal carcinoma growth in mice.FSP1+ fibroblasts promote skin carcinogenesis by maintaining MCP-1-mediated macrophage infiltration and chronic inflammation.Effect of acute exercise on prostate cancer cell growthSuppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14/BRAK transgenic mice.Impaired Cell Cycle Regulation in a Natural Equine Model of Asthma.Transcriptional profiles of pilocytic astrocytoma are related to their three different locations, but not to radiological tumor features.Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostateFibroblasts--a key host cell type in tumor initiation, progression, and metastasis.Carcinoma-Associated Fibroblasts Lead the Invasion of Salivary Gland Adenoid Cystic Carcinoma Cells by Creating an Invasive Track.Multifaceted tumor stromal fibroblastsInfiltrating bone marrow mesenchymal stem cells (BM-MSCs) increase prostate cancer cell invasion via altering the CCL5/HIF2α/androgen receptor signals.Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection.Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension.Paracrine effect of GTP cyclohydrolase and angiopoietin-1 interaction in stromal fibroblasts on tumor Tie2 activation and breast cancer growth.Fibroblasts as architects of cancer pathogenesisSmoking-induced CXCL14 expression in the human airway epithelium links chronic obstructive pulmonary disease to lung cancerCross-species functional analysis of cancer-associated fibroblasts identifies a critical role for CLCF1 and IL-6 in non-small cell lung cancer in vivo.Spatiotemporal expression and functional implication of CXCL14 in the developing mice cerebellum.Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation.Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression.Stromal fibroblasts present in breast carcinomas promote tumor growth and angiogenesis through adrenomedullin secretionA Crucial Role of CXCL14 for Promoting Regulatory T Cells Activation in StrokeCancer associated fibroblasts: the dark side of the coin.The tumor microenvironment: part 1.Targeting the tumor microenvironment by immunotherapy: part 2.
P2860
Q26770790-EA207B59-0CFD-41E5-824F-F311BD22CBA9Q26996836-62045E3D-3BE0-42F1-B671-0A88242CF08CQ27015980-3DB400E5-3C4A-4DF6-A0DC-72A6B2C1C82CQ30606334-A9B6E832-BB37-484F-BD96-62DFE98E20D0Q33498941-F6355386-A595-48CE-8FAD-AEF972B390EFQ33591332-73232972-1C8C-414F-ABB0-A1B66D439525Q33600872-CCB555AE-6B0F-44F9-ACAD-4376E73637FEQ33738887-638FA85F-4122-4796-812C-DE62C070C845Q33916413-C85D1A9A-96D8-4CA9-A9F5-2FFA6F5780B8Q33964324-A6FB9903-C345-4505-9B40-5E8770D57A43Q34010406-CE68049E-8BC5-4DC6-9A8D-36504718B502Q34115929-5CE865DF-988E-4CDC-A9C7-0E084098850CQ34393678-1A984A6F-CCBD-4D20-91AE-CC7F8D7606C6Q34549577-7D43D791-8D0C-4199-ABC1-EDCDD8DD0E8CQ34663710-0D9FD3C6-6133-4955-BC39-5853D899FF54Q34667999-9FEF9AC7-C285-4D95-BF0F-E2215DEF9124Q34760652-E46B8E74-DA50-4B61-B626-AAE6971B0B38Q34825681-FDE7134A-946C-4C1D-A898-6CE957A48093Q35172310-4D37F384-FC07-4A06-A9D4-9E5908DCC527Q35751484-9ABEA06A-4248-4CB2-8AF9-B93E2AB2FA40Q35819975-AE6A517B-9254-43AD-A4E4-6B38EE5F5977Q35838295-A50049BD-068B-4955-83EF-E445AF863602Q35920503-491551EC-0B23-4C7F-A500-98BF62926C7DQ35949286-AD5BA683-81D8-48C7-BBD7-6589AC29EC53Q36284975-FD3F734F-3C0C-4E80-83E9-E069B45A069CQ36413827-FF740F4C-8791-492A-9670-DC7AEF81E04DQ36552786-44D54D2F-13DE-404F-9112-C350395F5860Q36752368-2B9A111A-B91A-45F6-9875-79253BEC52F5Q36962605-A080D512-DD47-40E4-B8B3-70644AA29AF7Q37178453-2A328429-1039-4791-9200-8EC00A8C38EFQ37297975-9134427D-C18D-44FA-BA4F-E14079922B94Q37377875-D81E37AB-00D8-412C-AFFE-394412F05175Q37462031-BF7DC03B-1035-4596-BAE3-854CFAE2A97CQ37499246-3D0810A0-D4CC-4CBB-B62F-749DD7267B95Q37621644-122B18E7-4A70-4D7F-AABE-347332BAD56EQ37716611-74DFED32-AE1F-43B0-9FAB-A00A2D6FAB7FQ37738215-3AC50021-65F3-4C98-B463-A4087CCF8F36Q37943818-0F864308-2013-49EA-A5F2-C46C37BCB773Q37952794-1B700489-D632-4ED0-ACFF-C69FCD985905Q37952796-03411B67-C004-44EF-A036-862036BF6404
P2860
CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CXCL14 is an autocrine growth ...... ator of prostate tumor growth.
@en
CXCL14 is an autocrine growth ...... ator of prostate tumor growth.
@nl
type
label
CXCL14 is an autocrine growth ...... ator of prostate tumor growth.
@en
CXCL14 is an autocrine growth ...... ator of prostate tumor growth.
@nl
prefLabel
CXCL14 is an autocrine growth ...... ator of prostate tumor growth.
@en
CXCL14 is an autocrine growth ...... ator of prostate tumor growth.
@nl
P2093
P2860
P356
P1476
CXCL14 is an autocrine growth ...... ator of prostate tumor growth.
@en
P2093
Arne Ostman
Christina Hägglöf
Claudia Stolz
Eleonor Olsson
Lars Egevad
Martin Augsten
Mitchell J Frederick
Panagiotis Tsagozis
Patrick Micke
P2860
P304
P356
10.1073/PNAS.0813144106
P407
P577
2009-02-13T00:00:00Z